Acrivon Therapeutics, Inc.

NASDAQ ACRV Stock

Yield per half year: +40.43%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Acrivon Therapeutics, Inc.	Gilead Sciences	Amgen
Capitalization
Price	1.98	123.4	336.28
Price priv.
Number of shares, million	337.92	1255	541
Capitalization, billion	0.4562	150.63	154.17
EBITDA, billion	-0.0796	4.43	13.36
EV, billion	2	132.19	188.41
Profit and loss report
Net profit, billion	-0.0806	0.48	4.09
Revenue, bln, billion	0	28.75	33.42
EPS	-0.2384	0.3825	7.56
Balance
Assets, bln, billion	0.1966	59	91.84
Debt, bln, billion	0.0036	26.71	60.1
Balance cost, billion	0.1768	19.33	5.88
Cash, bln, billion	0.0398	9.99	11.97
Coefficients
Dividend yield, %	0	2.82	3.07
Dividend	0	3.93	9.52
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	0	4.02	4.2
P/BV	11.51	6	23.87
P/E	-5.66	240.57	34.3
Ev/Ebitda	-25.12	29.81	14.11
Debt/Ebitda	-0.0458	6.02	4.5
Efficiency
ROE	-54.07	2.28	67.55
ROA	-48.11	0.7926	4.33
ROIC	0	11.06	17
Ebitda margin	0	15.42	39.96
Net margin	0	1.67	12.24
Momentum
1 week, price changes	-0.5025 %	0 %	+6.56 %
1 month, price changes	+8.79 %	+4.15 %	+14.44 %
3 months, price changes	+54.69 %	+4.25 %	+13.43 %
6 months, price changes	+40.43 %	+20.39 %	+23.45 %
1 year, price changes	-71.63 %	+37.86 %	+5.34 %
3 years, price changes		+113.05 %	+47 %
5 years, price changes		+61.69 %	+45.49 %
10 years, price changes		+146.21 %	+217.51 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Shares

Tools

Community

Contacts

2025 © Investing Port
Contacts | Advertising
The use of porti.ru materials is permitted only if there is an active indexed link to the source.